MSD-ERTUGLIFLOZIN-METFORMIN 2.5/1000 ertugliflozin/metformin hydrochloride 2.5 mg/1000 mg film-coated tablet blister pack

Land: Australië

Taal: Engels

Bron: Department of Health (Therapeutic Goods Administration)

Werkstoffen:

metformin hydrochloride, Quantity: 1000 mg; ertugliflozin pyroglutamic acid, Quantity: 3.238 mg (Equivalent: ertugliflozin, Qty 2.5 mg)

Beschikbaar vanaf:

Merck Sharp & Dohme (Australia) Pty Ltd

farmaceutische vorm:

Tablet, film coated

Samenstelling:

Excipient Ingredients: sodium lauryl sulfate; crospovidone; magnesium stearate; povidone; Carnauba Wax; microcrystalline cellulose; titanium dioxide; hypromellose; hyprolose; iron oxide red

Toedieningsweg:

Oral

Eenheden in pakket:

14, 56

Prescription-type:

(S4) Prescription Only Medicine

therapeutische indicaties:

MSD-ERTUGLIFLOZIN-METFORMIN (ertugliflozin and metformin hydrochloride) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both ertugliflozin and metformin is appropriate. [see 5.1 PHARMACODYNAMIC PROPERTIES, Clinical trials and 4.2 DOSE AND METHOD OF ADMINISTRATION]

Product samenvatting:

Visual Identification: pink, oval, film-coated tablets debossed with '2.5/1000' on one side and plain on the other side.; Container Type: Blister Pack; Container Material: Al/Al; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Autorisatie-status:

Licence status A

Autorisatie datum:

2018-05-17